Case Reports in Infectious Diseases

Case Reports in Infectious Diseases / 2016 / Article

Case Report | Open Access

Volume 2016 |Article ID 9081352 | 3 pages |

A Rare Case of Streptococcus alactolyticus Infective Endocarditis Complicated by Septic Emboli and Mycotic Left Middle Cerebral Artery Aneurysm

Academic Editor: Larry M. Bush
Received24 May 2016
Accepted03 Jul 2016
Published21 Jul 2016


To date, S. alactolyticus endocarditis complicated by middle cerebral artery aneurysm has not been reported. We describe the case of a 65-year-old female with a history of hypertrophic cardiomyopathy with left ventricular outflow tract obstruction presenting with confusion and a apical holosystolic murmur. Angiography of the brain identified new bilobed left middle cerebral artery aneurysm. Serial blood cultures grew S. alactolyticus, and aortic and mitral valve vegetation were discovered on transesophageal echocardiography. The patient was treated with antimicrobial therapy, mitral and aortic valve replacements, and microsurgical clipping of cerebral aneurysm. This case serves to highlight the pathogenicity of a sparsely described bacterium belonging to the heterogenous S. bovis complex.

1. Introduction

S. equinus/S. bovis complex is a commensal group of nonenterococcal Group D Streptococcus species found within human and animal gastrointestinal tracts [1]. Certain species within the S. equinus/S. bovis complex, notably S. gallolyticus and S. infantarius, are known to cause human infections, such as bacteremia, meningitis, and endocarditis, and have a well-established association with colorectal carcinoma. S. alactolyticus is a rarely isolated species that constitutes the solitary species within DNA cluster IV of the S. equinus/S. bovis complex [2]. It has been isolated in the intestinal flora of pigs, chickens, pigeons, and canines, making it an almost exclusively animal-associated species [35]. Herein we describe the first case of S. alactolyticus endocarditis, complicated by septic emboli and mycotic cerebral aneurysm, in an immunocompetent human host.

2. Case Presentation

A 65-year-old Caucasian female presented to our institution with confusion and fevers. Her past medical history was notable for hypertension, hyperlipidemia, hypertrophic cardiomyopathy with left ventricular outflow tract obstruction, and mitral regurgitation. She had no prior surgeries but underwent routine dental cleaning four months prior to her presentation. Shortly after her dental procedure she developed episodic confusion and fevers prompting a brief admission to an outside medical facility where she underwent an unremarkable workup, including neurologic imaging, echocardiography, and blood cultures. She was ultimately discharged home with a ten-day course of levofloxacin to treat suspected bacteremia.

Eight weeks after discharge her symptoms worsened and she presented to our facility. She was lethargic and disoriented. Initial vital signs were remarkable for normal blood pressure, respiratory rate, and oxygen saturation on room air. She had resting tachycardia of 106 beats per minute and was normothermic. Physical examination revealed a grade 3/6 holosystolic murmur, as well as an intention tremor of the bilateral upper extremities. Laboratory evaluation revealed a normocytic anemia and a positive rheumatoid factor. Computed tomography (CT) of brain revealed mild enlargement of lateral ventricles disproportionate to the degree of volume loss. Lumbar puncture was performed, of which cerebrospinal fluid bacterial cultures, cytology, and viral PCR studies were negative. Records from her previous hospitalization were obtained and expert review of her previous echocardiogram raised suspicion for native valve infective endocarditis of both the aortic and mitral valves. Empiric antimicrobial therapy with vancomycin, gentamicin, and penicillin G was initiated, with noticeable improvement in the patient’s mentation within 48 hours. Serial blood cultures grew Streptococcus alactolyticus. Magnetic resonance imaging (MRI) of the brain revealed numerous areas of intraparenchymal and subarachnoid hemorrhage (Figure 1) concerning septic emboli. Cerebral angiogram showed left middle cerebral artery M2 segment mycotic aneurysm (Figure 2). Transesophageal echocardiogram (TEE) confirmed large mobile mitral and aortic valve vegetation with severe mitral and aortic regurgitation. CT of abdomen and pelvis showed new bilateral renal and splenic lesions, representing multiple small infarcts. Based on the Streptococcus alactolyticus sensitivities, antimicrobial therapy was deescalated to ceftriaxone, which was continued to complete a six-week course. She continued to have clinical improvement and her repeat blood cultures were negative. She was then treated with bioprosthetic aortic and mitral valve replacements. After an uncomplicated recovery from surgery she underwent definitive neurosurgical treatment of the left MCA mycotic aneurysm by left pterional craniotomy and microsurgical clipping. She recovered and was discharged to a rehabilitation facility with arrangements for outpatient colonoscopy to evaluate colonic malignancy.

3. Discussion

S. equinus/S. bovis complex, a group of nonenterococcal streptococci, is frequently found within the gastrointestinal tracts of humans and animals [1]. This complex has been isolated in 29–55% of individuals with Inflammatory Bowel Disease and colon cancer [6] and is responsible for up to 13% of cases of native valve endocarditis [7, 8]. However, it is worth noting that multiple genospecies exist within S. equinus/S. bovis complex and that the classically described association of S. equinus/S. bovis complex with colorectal cancer and native valve infective endocarditis does not seem to apply to all genospecies. These differences have caused some confusion in the classifications. Even so, performing a colonoscopy to evaluate colonic malignancy remains the prudent choice until more is known about the characteristics of the genospecies within this complex.

Efforts to streamline the nomenclature within the S. equinus/S. bovis complex have been undertaken, including PCR analysis of 16S ribosomal DNA sequences. These phylogenetic analyses have delineated the S. equinus/S. Bovis into four DNA homology clusters [2]. S. alactolyticus, the solitary genospecies in DNA cluster IV, is the infectious pathogen isolated in the case described.

The more prevalent S. gallolyticus, comprising DNA cluster III of the S. equinus/S. bovis complex, is a well-known inhabitant of the human gut microbiota; hence, it is the species most notoriously associated with native valve infective endocarditis and colon cancer [2]. S. alactolyticus, as opposed to S. gallolyticus, is almost an exclusively animal-associated species and has been isolated from the intestinal flora of pigs, chickens, pigeons, and canines [35]. Human reports of S. alactolyticus infection are exceedingly rare. Most recently, Toepfner et al. described a fatal case of fulminant neonatal sepsis and respiratory distress syndrome due to this pathogen [9].

Our patient presented with renal, splenic, and intracerebral infarcts, as well as an intracerebral mycotic aneurysm, in the setting of S. alactolyticus bacteremia and native valve left-sided endocarditis. Research suggests that septic emboli occur in 22–43% of patients with infective endocarditis [10] and can cause irreversible end-organ damage throughout the body by occlusion of the arterial lumen. Despite the high rates of embolism, only 1–5% of patients develop symptomatic mycotic aneurysms [11]. The most common locations for mycotic aneurysms include intracranial, visceral abdominal, and extremity arteries, with predisposition for involving sites of bifurcation [11]. Given their virulent nature Staphylococcus spp. and Salmonella spp. are the two most common causative pathogens. However, our case illustrates the first reported case of symptomatic left middle cerebral mycotic aneurysm caused by S. alactolyticus, a scarcely virulent species. One of the most catastrophic complications of mycotic aneurysms is subarachnoid hemorrhage and aneurysmal rupture, the latter accounting for 80% mortality rate [12]. Despite the stated risks, our patient underwent bioprosthetic aortic and mitral valve replacements requiring heparinization, followed by microsurgical clipping of the left MCA mycotic aneurysm.

4. Conclusion

Despite historical clinical practice, it has been demonstrated that there is significant heterogeneity in the clinical manifestations of members within the S. equinus/S. bovis complex. We present a unique case in which S. alactolyticus, S. equinus/S. bovis complex subspecies primarily associated with animal pathogenicity, caused life-threatening infection in an immunocompetent adult female. This group should no longer be perceived as a single bacterial entity, as routine efforts to identify specific S. equinus/S. bovis complex subspecies will aid in identification and recognition of their unique clinical characteristics.

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Competing Interests

The authors declare that they have no competing interests.

Authors’ Contributions

Patricia Almeida, D.O., contributed to intellectual content, literature search, paper preparation, and paper editing. She takes responsibility for the integrity of this work from its inception to published paper and is designated as “guarantor.” Jaclyn Railsback, D.O., contributed to intellectual content, literature search, paper preparation, and paper editing. James Benjamin Gleason, M.D., contributed to intellectual content, literature search, paper preparation, and paper editing. This paper has been read and approved by all the authors.


  1. C. Jans, L. Meile, C. Lacroix, and M. J. A. Stevens, “Genomics, evolution, and molecular epidemiology of the Streptococcus bovis/Streptococcus equinus complex (SBSEC),” Infection, Genetics and Evolution, vol. 33, pp. 419–436, 2015. View at: Publisher Site | Google Scholar
  2. L. Schlegel, F. Grimont, E. Ageron, P. A. D. Grimont, and A. Bouvet, “Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov,” International Journal of Systematic and Evolutionary Microbiology, vol. 53, no. 3, pp. 631–645, 2003. View at: Publisher Site | Google Scholar
  3. L. A. Devriese, P. Vandamme, B. Pot, M. Vanrobaeys, K. Kersters, and F. Haesebrouck, “Differentiation between Streptococcus gallolyticus strains of human clinical and veterinary origins and Streptococcus bovis strains from the intestinal tracts of ruminants,” Journal of Clinical Microbiology, vol. 36, no. 12, pp. 3520–3523, 1998. View at: Google Scholar
  4. R. W. Bentley, J. A. Leigh, and M. D. Collins, “Intrageneric structure of Streptococcus based on comparative analysis of small-subunit rRNA sequences,” International Journal of Systematic Bacteriology, vol. 41, no. 4, pp. 487–494, 1991. View at: Publisher Site | Google Scholar
  5. M. L. Rinkinen, J. M. K. Koort, A. C. Ouwehand, E. Westermarck, and K. J. Björkroth, “Streptococcus alactolyticus is the dominating culturable lactic acid bacterium species in canine jejunum and feces of four fistulated dogs,” FEMS Microbiology Letters, vol. 230, no. 1, pp. 35–39, 2004. View at: Publisher Site | Google Scholar
  6. R. S. Klein, R. A. Recco, M. T. Catalano, S. C. Edberg, J. I. Casey, and N. H. Steigbigel, “Association of Streptococcus bovis with carcinoma of the colon,” The New England Journal of Medicine, vol. 297, no. 15, pp. 800–803, 1977. View at: Publisher Site | Google Scholar
  7. J. Waisberg, C. D. O. Matheus, and J. Pimenta, “Infectious endocarditis from Streptococcus bovis associated with colonic carcinoma: case report and literature review,” Arquivos de Gastroenterologia, vol. 39, no. 3, pp. 177–180, 2002. View at: Publisher Site | Google Scholar
  8. A. Ferrari, I. Botrugno, E. Bombelli, T. Dominioni, E. Cavazzi, and P. Dionigi, “Colonoscopy is mandatory after Streptococcus bovis endocarditis: a lesson still not learned: case report,” World Journal of Surgical Oncology, vol. 6, article 49, 2008. View at: Publisher Site | Google Scholar
  9. N. Toepfner, S. Shetty, M. Kunze et al., “Fulminant neonatal sepsis due to Streptococcus alactolyticus-a case report and review,” APMIS, vol. 122, no. 7, pp. 654–656, 2014. View at: Publisher Site | Google Scholar
  10. J. M. Steckelberg, J. G. Murphy, D. Ballard et al., “Emboli in infective endocarditis: the prognostic value of echocardiography,” Annals of Internal Medicine, vol. 114, no. 8, pp. 635–640, 1991. View at: Publisher Site | Google Scholar
  11. L. M. Baddour, W. R. Wilson, A. S. Bayer et al., “Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association,” Circulation, vol. 132, no. 15, pp. 1435–1486, 2015. View at: Publisher Site | Google Scholar
  12. A. V. Salgado, A. J. Furlan, and T. F. Keys, “Mycotic aneurysm, subarachnoid hemorrhage, and indications for cerebral angiography in infective endocarditis,” Stroke, vol. 18, no. 6, pp. 1057–1060, 1987. View at: Publisher Site | Google Scholar

Copyright © 2016 Patricia Almeida et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

1276 Views | 392 Downloads | 3 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.